Drug Pipeline

FOLFIRI Regimen Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
3
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-11 NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without…		 Trial sites expanded: 286 -> 290 locations
2026-06-11 NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without…		 date change Primary completion pushed: 2028-01-31 -> 2028-09-25
2026-06-11 NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without…		 date change Completion pushed: 2031-08-31 -> 2032-04-25
Active Studies by Phase
Phase 3
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… Metastatic Colorectal Cancer Recruiting
NCT04793958 Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced… Advanced Colorectal Cancer Active, Not Recruiting
Early Phase 1
NCT07486492 Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer Colorectal Cancer Metastatic Not Yet Recruiting
Sponsors Running FOLFIRI Regimen Trials
Mirati Therapeutics Inc. (1) Amgen (1) The First Affiliated Hospital of Xiamen University (1)
Disease Areas
Colorectal Cancer (3)
Get alerts when FOLFIRI Regimen trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free